• Explore /
  • Poster
  • / Everolimus and sunitinib as first- and second-line treatments of patients with metastatic papillary renal cell carcinoma (pRCC): A retrospective study of the GETUG (Groupe Français d’Etude des Tumeurs Uro-Génitales).

Everolimus and sunitinib as first- and second-line treatments of patients with metastatic papillary renal cell carcinoma (pRCC): A retrospective study of the GETUG (Groupe Français d’Etude des Tumeurs Uro-Génitales).

Abstract Poster

Authors

null

Claude Linassier

Oncologie Medicale, Tours, France

Claude Linassier , Laurence Albiges , Christine Chevreau , Brigitte Laguerre , Stephane Oudard , Marine Gross-Goupil , Gwenaelle Gravis , Francois Goldwasser , Frederic Rolland , Remy Delva , Laura Moise , Jean-Marc Tourani Sr., Cecile Vassal , Sylvie Zanetta , Nicolas Penel , Aude Flechon , Christine Theodore , Philippe Barthelemy , Carolina Saldana , Bernard Escudier

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 505)

DOI

10.1200/jco.2016.34.2_suppl.505

Abstract #

505

Poster Bd #

D10

Abstract Disclosures

Similar Posters

First Author: Sike He

First Author: Darren R. Feldman

First Author: Gabriel Tremblay

First Author: Jose Manuel Ruiz Morales